Health care reform must ensure that quality coverage is affordable and accessible for every American, regardless of income or pre-existing conditions. But it must not force Americans into a government-run health care system that would eliminate coverage they receive from their employer. Nor must it mandate that business or individuals pay for coverage. Every American must have the right to choose the health plan that best meets their needs and medical decisions must be made by patients and doctors, not government bureaucrats.
More on Health Care
WASHINGTON, D.C. – Congressman Michael T. McCaul (R-TX), the Lead Republican on the Foreign Affairs Committee and the Chairman Emeritus on the House Homeland Security Committee, released a statement on his support for pre-existing conditions and the sham H.R. 986 vote:
WASHINGTON, D.C. – Congressman Michael T. McCaul (R-TX), the Lead Republican on the Foreign Affairs Committee and the Chairman Emeritus on the House Homeland Security Committee, released a statement on H.Res. 271 and his support for preexisting conditions:
WASHINGTON, D.C. – Congressman Michael McCaul (TX-10), Chairman of the House Homeland Security Committee and a senior member of the House Foreign Affairs Committee, applauds the House passage of the Fiscal Year 2019 Defense, Health, and Education funding bill.
This Congress has now passed the most funding bills on time in 22 years. The Senate passed this bill last week by a vote of 93 to 7 and it will now head to the President’s desk for his signature.
WASHINGTON, D.C. – Five lawmakers introduced a bipartisan bill giving a full range of medical services to families with children who have life-limiting illnesses and who qualify for Medicaid, which currently has gaps in such coverage.
WASHINGTON, DC – U.S. Representatives Michael McCaul (R-TX), G. K. Butterfield (D-NC), Mike Kelly (R-PA), and Jackie Speier (D-CA) along with Senators Jack Reed (D-RI), Shelley Moore Capito (R-WV), Chris Van Hollen (D-MD), and Johnny Isakson (R-GA) today announced that their bipartisan bill, the Childhood Cancer STAR (Survivorship, Treatment, Access, and Research) Act, was signed into law by President Trump last night.
When Rep. Michael McCaul was in grade school, he lost his best friend to cancer. It has always affected him, especially when he meets with constituents whose children are sick.
And then three years ago, he met an inspiring new friend.
Sadie Keller was diagnosed with leukemia in 2015 when she was seven. She came to Capitol Hill from Texas to lobby Congress in March 2016 and met McCaul for the first time.
“I met him and I told him everything, what we’re doing and what we’re trying to accomplish. He said that was awesome,” said Sadie, now 10.
Families struggling with childhood cancer could soon have more options. That’s after President Trump signed the RACE for Children Act, a new law that allows drugs that fight cancer for adults to be tested and regulated to fight childhood cancer. The law was sponsored by Central Texas Republican Congressman Michael McCaul, R-Austin.
It’s not a normal day at Twin Creeks Country Club in Cedar Park. Yes, the golfing is there but rarely has there been such a cause behind it.
A new law, introduced by U.S. Rep. Michael McCaul, R-Austin, and a group of bipartisan lawmakers, could make it easier for children with cancer to battle the disease with the help of adult cancer drugs.
The Research to Accelerate Cures and Equity for Children Act – or RACE for Children Act – gives the U.S. Food and Drug Administration authority to require that adult cancer drugs be studied for safety and effectiveness in children battling the disease. President Donald Trump signed the legislation Friday.
WASHINGTON, D.C. – Today, Congressman Michael McCaul (TX-10) – Chairman of the Homeland Security Committee and a senior member of the Foreign Affairs Committee – applauds President Trump for signing RACE for Children Act (Research to Accelerate Cures and Equity for Children Act) into law.
RACE will now allow the most innovative adult treatments for cancer to be studied for use in children.